BridgeBio Gets First Drug Approval In Ultra-Rare MoCD Type A

 
• By Joseph Haas
  
FDA approved background, 3D rendering, blue street sign
Nulibry for MoCD type A is BridgeBio's first approved drug
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip